BioForce Nanosciences Holdings, Inc.
BFNH
$1.79
$0.010.56%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 474.20K | 490.00K | 495.40K | 501.50K | 493.10K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 474.20K | 490.00K | 495.40K | 501.50K | 493.10K |
| Operating Income | -474.20K | -490.00K | -495.40K | -501.50K | -493.10K |
| Income Before Tax | -459.70K | -1.29M | -1.30M | -1.30M | -1.30M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.46 | -1.29 | -1.30 | -1.30 | -1.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -459.70K | -1.29M | -1.30M | -1.30M | -1.30M |
| EBIT | -474.20K | -490.00K | -495.40K | -501.50K | -493.10K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.01 | -0.04 | -0.04 | -0.04 | -0.04 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.04 | -0.04 | -0.04 | -0.04 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 134.09M | 132.82M | 128.56M | 124.31M | 120.06M |
| Average Diluted Shares Outstanding | 134.09M | 132.82M | 128.56M | 124.31M | 120.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |